About 1 Trademarks found for “SATISILVER”

Cannabis; medical marihuana; cannabis products, namely cannabis; cannabis namely marihuana; cannabis namely medical marihuana; cannabis products namely cannabis for medical use; dried plant material derived from the cannabis plant

Plant seeds, namely agricultural seeds; cards, namely membership and medical identification cards; cards for use in connection with customer loyalty, reward, bonus point, and discount programs; pharmaceuticals for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals containing one or more cannabinoids as the active ingredient; pharmaceuticals, nutraceuticals and consumer products containing cannabis, cannabinoids or cannabis compounds; cannabis products, namely hashish, cannabis seeds; cannabis products, namely cannabis, medicines, and medicines containing a tetrahydrocannabinol extract, for clinical studies; cannabinoids or cannabis compounds for use in pharmaceuticals; cannabis compounds, namely medicines containing a tetrahydrocannabinol extract; cannabis based pharmaceuticals and nutraceuticals; cannabis preparations and derivative products in the form of personal care preparations for the body, namely, creams, oils, emollients, ointments, rubs, lotions, and salves; cannabis products namely hashish for medical use; narcotics for medical use; cannabis seeds and cannabis plants; nutritional and dietary supplements for general health and well-being; pharmaceutical preparations for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceutical preparations containing one or more cannabinoids as the active ingredient; medicines containing a tetrahydrocannabinol extract; medicines derived from cannabis; products, plants, seeds and medicines derived from and related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; cosmetics with cannabinoid content